FINWIRES · TerminalLIVE
FINWIRES

Oppenheimer Raises Biogen Price Target to $300 From $275, Maintains Outperform Rating

By

Biogen (BIIB) has an average rating of overweight and mean price target of $0, according to analysts polled by FactSet.

Price: $194.50, Change: $-10.03, Percent Change: -4.90%

Related Articles